New screening advances target the 1-in-8 lifetime risk of prostate cancer diagnosis episode artwork

EPISODE · Sep 7, 2026 · 9 MIN

New screening advances target the 1-in-8 lifetime risk of prostate cancer diagnosis

from Onpode

Prostate cancer is the most common solid organ cancer in men and the fifth leading cause of cancer-related deaths globally. Epidemiologic data consistently place a man's lifetime diagnosis risk at approximately 1 in 8. The American Cancer Society projects 333,830 new U.S.

Episode metadata supplied by the publisher feed · Published Sep 7, 2026

Embed this episode

Ready to play

New screening advances target the 1-in-8 lifetime risk of prostate cancer diagnosis

0:00 9:07

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Onpode?

This episode is 9 minutes long.

When was this Onpode episode published?

This episode was published on September 7, 2026.

Can I download this Onpode episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!